Aerosol Therapy in Acute and Chronic Respiratory Disease

Archives of Internal Medicine

Volumn 131, Issue 1, 1973, Pages 148-155

  Miller, William F ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ADRENERGIC RECEPTOR STIMULATING AGENT; ALCOHOL DERIVATIVE; ANTIBIOTIC AGENT; BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CROMOGLYCATE DISODIUM; DEOXYRIBONUCLEASE; DETERGENT; GLUCOCORTICOID; OCTANOL; PROPANEDIOL DERIVATIVE; SODIUM CHLORIDE; XANTHINE DERIVATIVE;

AEROSOL; AIRWAY OBSTRUCTION; ARTIFICIAL VENTILATION; HUMAN; RESPIRATORY TRACT DISEASE; REVIEW;

ACETYLCYSTEINE; AEROSOLS; AIRWAY OBSTRUCTION; ALCOHOLS; ANTIBIOTICS; BRONCHODILATOR AGENTS; CROMOLYN SODIUM; DEOXYRIBONUCLEASES; DETERGENTS; GLUCOCORTICOIDS; HUMAN; OCTANOLS; PARASYMPATHOLYTICS; PROPYLENE GLYCOLS; RESPIRATORY THERAPY; RESPIRATORY TRACT DISEASES; SODIUM CHLORIDE; SYMPATHOMIMETICS; XANTHINES;

EID: 0015535049     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.1973.00320070144016     Document Type: Article

References (54)

1. Da Costa JM: Inhalations in the Treatment of Diseases of Respiratory Passages, Particularly as Affected by the Use of Atomized Fluids. Philadelphia, JB Lippincott Co, 1867, pp 10-11.
2. Beigel H: On Inhalations, as a Means of Local Treatment of the Organs of Respiration by Atomized Fluids and Gases. London, R. Hardwicke, 1866, pp 4-5.
3. Magni Hippocratis Opera Omnia, in De Morbis, vol 2, chapter 5, Geneva, 1657.
4. Miller WF, Johnston FF, Tarkoff MP: Use of ultrasonic aerosols with ventilatory assistors. J Asthma Res 5:335-354, 1968.
5. The treatment of cystic fibrosis: A statement by the committee on therapy, American Thoracic Society. Am Rev Resp Dis 97:730-734, 1968.
6. Denton R: Bronchial secretions in cystic fibrosis. Am Rev Resp Dis 86:41-46, 1962.
7. Cushing IE, Miller WF: Nebulization therapy, in Safar P (ed): Respiratory Therapy, ed 2. Philadelphia, FA Davis Co, to be published.
8. Parks CR: Mist therapy: Rationale and practice. Pediat Pharmacol Ther 76:305-313, 1970.
9. Graeser JB, Rowe AH: Inhalation of epinephrine for the relief of asthmatic symptoms. J Allergy 6:415-420, 1935.
10. Ariëns EJ: Pharmacology of bronchodilating and bronchoconstricting drugs, in Orie NGM, Sluiter HJ: Bronchitis II. Assen, Netherlands, Royal Van Gorcum Ltd, 1964, pp 209-238.
11. Kennedy MC, Thursby-Pelham D: Some adrenergic drugs and atropine methonitrate given by inhalation for asthma: A comparative study. Br Med J 1:1018-1021, 1964.
12. Dautrebande L: Microaerosols. New York, Academic Press Inc, 1962.
13. Kallos P, Kallos-Deffner L: Comparison of the protective effect of isoproterenol with isoproterenol-phenylephrine aerosols in asthmatics. Int Arch Allergy Appl Immunol 24:17-26, 1964.
14. Patterson CD, Kamp GH: Retention of liquid aerosols in the lung. Am Rev Resp Dis 95:443-446, 1967.
15. Graff TD, Benson DW: Systemic and pulmonary changes with inhaled humid atmospheres. Anesthesiology 30:199-207, 1969.
16. Chinard FP: The permeability characteristics of the pulmonary blood-gas barrier, in Caro CG (ed): Advances in Respiratory Physiology. Baltimore, Williams & Wilkins Co, 1966, p 106.
17. Walkenhorst W, Dautrebande L: New studies on aerosols no. 23: Experimental observations on various factors influencing weight, number, flowrate and size distribution of aerosol particles. Arch Int Pharmacodyn 150:264-294, 1964.
18. Modell JH, Heinitsh H, Giammona ST: The effects of wetting and antifoaming agents on pulmonary surfactant. Anesthesiology 30:164-173, 1969.
19. Modell JH, Giammona ST, Alvarez LA: Effect of ultrasonic nebulized suspensions on pulmonary surfactant. Dis Chest 50:627-629, 1966.
20. Palmer KNV: Effect of an aerosol detergent in chronic bronchitis. Lancet 1:611-613, 1957.
21. Paez PN, Miller WF: Surface active agents in sputum evacuation. Chest 60:312-317, 1971.
22. Finley TN: Pulmonary surface activity and the problems of atelectasis, wetting, foaming, and detergency in the lung. Anesth Analg 42:35-42, 1963.
23. Hirsch SR, Zastrow JE, Kory RC: Sputum liquefying agents: A comparative in vitro evaluation. J Lab Clin Med 74:346-353, 1969.
24. Palmer KNV: A new mucolytic agent by aerosol for inhalation in chronic bronchitis. Lancet 2:802-804, 1961.
25. Waldron-Edward D, Skoryna SC: The mucolytic activity of amides: A new approach to mucus dispersion. Can Med Assoc J 94:1249-1256, 1966.
26. Licherman J: The appropriate use of mycolytic agents. Am J Med 49:1-4, 1970.
27. Webb WR: Clinical evaluation of a new mucolytic agent, acetyl-cysteine. J Thorac Cardiovasc Surg 44:330-343, 1962.
28. Solomons CC, Cotton EK, Dubois R: The use of buffered L-arginine in the treatment of cystic fibrosis. Pediatrics 47:384-389, 1971.
29. Matthews LW, Doershuck CF: Inhalation therapy and postural drainage for the treatment of cystic fibrosis. Bibl Paediat 86:297-314, 1967.
30. Miller WF: Physical therapy procedures in the management of chronic obstructive respiratory insufficiency. Inhalation Ther 13:70-76, 1968.
31. Kane IJ: Segmental postural drainage in pulmonary disease. Dis Chest 23:418-427, 1953.
32. Beck GJ: Chronic bronchial asthma and emphysema: Rehabilitation and use of thoracic vibrocompression. Geriatrics 21:139-158, 1966.
33. Barach AL, Molomut M, Soroka M: Inhalation of promin in experimental tuberculosis. Am Rev Tuberc 46:268-276, 1942.
34. Potter JL, et al: Complex formation between basic antibiotics and deoxyribonucleic acid in human pulmonary secretions. Pediatrics 36:714-720, 1965.
35. Spier R, Witebsky E, Paine JR: Aerosolized pancreatic dornase and antibiotics in pulmonary infections: Use in patients with postoperative and nonoperative infections. JAMA 178:878-886, 1961.
36. Lifschitz MI, Denning CR: Safety of kanamycin aerosol. Clin Pharmacol Ther 12:91-95, 1971.
37. Bilodeau M, Roy JC, Giroux M: Studies of absorption of kanamycin by aerosolization. Ann NY Acad Med 132:870-878, 1966.
38. High RH, Sarria A, Huang NN: Kanamycin in the treatment of infections in infants and children. Ann NY Acad Sci 76:289-307, 1958.
39. Reeder WH, Mackey GS: Nebulized cortisone in bacterial pneumonia. Dis Chest 18:528-534, 1950.
40. Linder WR: Adrenal suppression by aerosol steroid inhalation. Arch Intern Med 113:655-656, 1964.
41. Crepea SB: Inhalation corticosteroid (dexamethasone PO4) management of chronically asthmatic children. J Allergy 34:119-126, 1963.
42. Luisada AA, Goldmann MA, Weyl R: Alcohol vapor by inhalation in the treatment of acute pulmonary edema. Circulation 5:363-369, 1952.
43. Reich NE, Rosenberg BA, Metz M: The use of 2-ethylhexanol in acute pulmonary edema. Dis Chest 22:43-49, 1953.
44. Pattle RE: A test of silicon antifoam treatment of lung oedema in rabbits. J Path Bact 72:203-209, 1956.
45. McClenahan JB, Mussenden R, Ohlsen JD: Effect of ethanol on surfactant of ventilated lungs. J Appl Physiol 27:90-95, 1969.
46. Obenour RA, et al: Effects of surface-active aerosols and pulmonary congestion on lung compliance and resistance. Circulation 28:888-892, 1963.
47. Boyd EM, Sheppard EP: Expectorant action of inhaled alcohol. Arch Otolaryngol 90:374-379, 1969.
48. Gençer F: A new method in acute pulmonary edema: Hyaluronidase-spraying method. Cardiologia 31:469-474, 1957.
49. Howell JBL, Altounyan REC: A double-blind trial of disodium cromoglycate in the treatment of allergic bronchial asthma. Lancet 2:539-543, 1967.
50. Altounyan REC: Inhibition of experimental asthma by a new compound “Intal.” Acta Allergol 22:487, 1967.
51. Cox JSG: Disodium cromoglycate (FPL 670) (Intal): A specific inhibitor of reagenic antibody-antigen mechanisms. Nature 216:1328-1329, 1967.
52. Blackhall MI, Jones RS: Effect of Intal on post-exercise bronchoconstriction asthma, in Pepys J, Franklin AW (eds): Disodium Cromoglycate in Allergic Airways Disease. London, Butterworths, 1970, pp 163-168.
53. Cox JSG, et al: Disodium cromoglycate, in Harper NJ, Simmons AB (eds): Advances in Drug Research. New York, Academic Press, 1970.
54. Burger LW, Elliott RM: A perspective on the role of cromolyn sodium as an antiasthmatic agent. Chest 60:210-213, 1971.